Cargando…
Immunogenicity and safety of two monovalent rotavirus vaccines, ROTAVAC® and ROTAVAC 5D® in Zambian infants
BACKGROUND AND AIMS: ROTAVAC® (frozen formulation stored at −20 °C) and ROTAVAC 5D® (liquid formulation stable at 2–8 °C) are rotavirus vaccines derived from the 116E human neonatal rotavirus strain, developed and licensed in India. This study evaluated and compared the safety and immunogenicity of...
Autores principales: | Chilengi, R., Mwila- Kazimbaya, K., Chirwa, M., Sukwa, N., Chipeta, C., Velu, R.M., Katanekwa, N., Babji, S., Kang, G., McNeal, M.M., Meyer, N., Gompana, G., Hazra, S., Tang, Y., Flores, J., Bhat, N., Rathi, N. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Science
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8204902/ https://www.ncbi.nlm.nih.gov/pubmed/33992437 http://dx.doi.org/10.1016/j.vaccine.2021.04.060 |
Ejemplares similares
-
Risk of intussusception after monovalent rotavirus vaccine (Rotavac) in Indian infants: A self-controlled case series analysis
Publicado: (2021) -
Introduction of rotavirus vaccination in Palestine: An evaluation of the costs, impact, and cost-effectiveness of ROTARIX and ROTAVAC
por: Debellut, Frédéric, et al.
Publicado: (2020) -
Introducing ROTAVAC® to the occupied Palestinian Territories: Impact on diarrhea incidence, rotavirus prevalence and genotype composition
por: Rennert, Wolfgang, et al.
Publicado: (2023) -
Evaluation of ROTARIX(®) Booster Dose Vaccination at 9 Months for Safety and Enhanced Anti-Rotavirus Immunity in Zambian Children: A Randomised Controlled Trial
por: Laban, Natasha Makabilo, et al.
Publicado: (2023) -
Diarrheal Etiology and Impact of Coinfections on Rotavirus Vaccine Efficacy Estimates in a Clinical Trial of a Monovalent Human–Bovine (116E) Oral Rotavirus Vaccine, Rotavac, India
por: Praharaj, Ira, et al.
Publicado: (2019)